Defence Therapeutics Inc. (DTC) — Net Asset Quality Index
Defence Therapeutics Inc. (DTC) has a Net Asset Quality Index of -89.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.37 Million minus total liabilities of €2.59 Million yields net assets of €-1.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Defence Therapeutics Inc. assets under control for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Defence Therapeutics Inc. Net Asset Quality Index Over Time (2020–2024)
This chart shows how Defence Therapeutics Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of December 2025, the index stands at -89.4%, representing net assets of €-1.22 Million against total assets of €1.37 Million EUR. See DTC current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Defence Therapeutics Inc. (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for Defence Therapeutics Inc. from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Defence Therapeutics Inc. stock valuation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -750.2% | €-3.58 Million | €477.75K | €4.06 Million | ▼ -794.6 pp |
| 2023 | 44.3% | €1.57 Million | €3.53 Million | €1.97 Million | ▲ +98.2 pp |
| 2022 | -53.9% | €-387.56K | €719.67K | €1.11 Million | ▼ -151.7 pp |
| 2021 | 97.8% | €5.49 Million | €5.61 Million | €122.26K | ▲ +0.3 pp |
| 2020 | 97.5% | €1.86 Million | €1.91 Million | €48.35K | — |